Condition (MeSH)
Alkalosis
ClinicalTrials.gov lists 18 trials for Alkalosis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
10 of the 18 trials are tagged with Alkalosis itself; the rest are tagged with a narrower condition beneath it.
When did Alkalosis trials start? (9)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 4
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2023 | 1 |
| 2019 | 2 |
| 2018 | 4 |
| 2017 | 2 |
| 2013 | 1 |
| 2012 | 2 |
| 2011 | 3 |
| 2010 | 2 |
| 2002 | 1 |
No forecast is made for this condition: it averages 0.2 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: none of the 18 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Alkalosis trials in? (5)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 2/3 | 1 |
| Phase 3 | 2 |
| Phase 4 | 1 |
| Not applicable | 7 |
| Observational | 7 |
How many Alkalosis trials are recruiting? (4)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 1 |
| Completed | 11 |
| Terminated | 1 |
| Unknown status | 5 |
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which drugs are being tested for Alkalosis? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Carbogen | 1 |
| Antacid | 1 |
Interventions as named in the registry (2)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Acetazolamide Pill | 3 |
| sodium bicarbonate 8.4% | 1 |
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which publications cover Alkalosis? (40)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| The Magnitude of the Blood Acid-Base Response, but Not Time to Peak, Is Reliable Following the Ingestion of Acute, Individualized Sodium Citrate. | International journal of sport nutrition and exercise metabolism | 2025 | Yes |
| Acid-Base Disorders in the Critically Ill Patient. | Clinical journal of the American Society of Nephrology : CJASN | 2023 | Yes |
| Cerebrospinal fluid and arterial acid-base equilibria in spontaneously breathing third-trimester pregnant women. | British journal of anaesthesia | 2022 | Yes |
| Factors Influencing Blood Alkalosis and Other Physiological Responses, Gastrointestinal Symptoms, and Exercise Performance Following Sodium Citrate Supplementation: A Review. | International journal of sport nutrition and exercise metabolism | 2021 | Yes |
| Treatment of severe metabolic alkalosis in a patient with congestive heart failure. | American journal of kidney diseases : the official journal of the National Kidney Foundation | 2013 | Yes |
Showing 5 of 40 publications.
Sub-conditions in MeSH (1)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: lead sponsors, serious adverse events in this condition's trials, prevalence, and rare-disease identity.